Skip to content

Early Human Milk Fortification After Early, Exclusive, Enteral Nutrition in Very Preterm Infants

Early Human Milk Fortification After Early, Exclusive, Enteral Nutrition in Very Preterm Infants: a Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05525585
Acronym
ENACT+
Enrollment
80
Registered
2022-09-01
Start date
2022-11-17
Completion date
2027-05-01
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enteral Feeding Intolerance, Light-For-Dates, Prematurity

Brief summary

In this proposed clinical trial, the investigators will randomize 80 very preterm (VPT) infants to receive either early (between day 4 and 7) or delayed (between day 10 and 14) fortification and determine if providing early protein supplementation through early fortification results in higher FFM-for-age z scores and more diversity in the gut microbiome.

Interventions

DIETARY_SUPPLEMENTEarly HMF

Mom's milk or donor milk will be fortified between postnatal day 4 and 7

DIETARY_SUPPLEMENTDelayed HMF

Mom's milk or donor milk will be fortified between postnatal day 10 and 14

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER
Mead Johnson Nutrition
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 4 Days
Healthy volunteers
No

Inclusion criteria

* Gestational age 29 to 33 weeks of gestation * Birth weight \< 1800 g * Postnatal age \< 96 hours

Exclusion criteria

* Small for gestational age (\<5th percentile) * Major congenital/chromosomal anomalies * Terminal illness needing withhold or limit support

Design outcomes

Primary

MeasureTime frameDescription
Fat-free mass(FFM)-for-age Z-scorePostnatal day 14 to 21Estimated by air displacement plethysmography

Secondary

MeasureTime frameDescription
Fecal microbiome compositionBirth to 36 weeks postmenstrual ageDetermined by 16S RNA sequencing of bacteria in stool samples
Growth - WeightBirth to 36 weeks postmenstrual age or hospital dischargeMeasured weekly in grams and z scores as part of routine care
Growth - LengthBirth to 36 weeks postmenstrual age or hospital dischargeMeasured weekly in cm and z scores as part of routine care
Growth - Head circumferenceBirth to 36 weeks postmenstrual age or hospital dischargeMeasured weekly in cm and z scores as part of routine care
Growth rateBirth to 36 weeks postmenstrual age or hospital dischargeWeight gain in g/kg/day
Number of participants with postnatal growth falteringBirth to 36 weeks postmenstrual age or hospital dischargeDiagnosis of growth faltering (decline in weight-for-age z score from birth to 36 weeks postmenstrual age greater than 1.2
Number of participants with diagnosis of necrotizing enterocolitisBirth to 60 days or dischargeDiagnosis of necrotizing enterocolitis stage 2 or 3
Number of participants with diagnosis of intestinal perforationBirth to 10 daysDiagnosis of intestinal perforation
DeathBirth to 60 daysDeath prior to postnatal day 60
Duration of hospital stay in daysBirth to 60 days or discharge, whichever occurs firstFrom day of admission to day of hospital discharge to home

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAriel A. Salas, MD, MSPH

University of Alabama at Birmingham

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 16, 2026